By Editor , 17 September 2026
AMP Adds Tema Medicina's ATTIVA Subdermal RF Platform

Cordova, Tenn. – September 16, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

By Editor , 17 September 2026
Triple B Media Launches SLVR FAST Channel With LA Kings

Los Angeles – September 11, 2026 -- Triple B Media has struck a partnership with Silver Sports & Entertainment to operate SLVR, a new free ad-supported streaming television (FAST) channel programmed by the Los Angeles Kings and its AHL affiliate, the Ontario Reign.

By Editor , 17 September 2026
March Networks, VIVOTEK Debut Joint GSX Booth as Merger Bears Fruit

Atlanta – September 16, 2026 -- March Networks and VIVOTEK will make their first joint appearance at Global Security Exchange (GSX) 2026, five months after their April merger, showcasing new product integrations and a customer deployment with a North American apparel chain operating more than 500 stores.

By Editor , 17 September 2026
CINC Systems Launches Community Intelligence, Cites $1.13M in AI Savings

Duluth, Ga. – September 16, 2026 -- CINC Systems has unveiled Community Intelligence, a platform-wide AI standard the company says has already helped clients save more than 36,000 hours and $1.13 million in labor costs year to date across invoice, budget and board packet workflows.

By Editor , 17 September 2026

Unnao, India -- Crown Holdings, Inc. (NYSE: CCK) broke ground on September 9, 2026 on its first beverage can manufacturing facility in India, a plant designed to produce approximately 2.2 billion aluminum beverage cans annually once operational.

By Editor , 17 September 2026
Eloxx Doses First Patients in Phase 2b Alport Syndrome Trial

Arlington, Mass. – – September 16, 2026 -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) has dosed the first two patients in the EXACT Study, a Phase 2b trial evaluating its investigational drug exaluren in patients with nonsense mutation Alport syndrome (NMAS), a rare kidney disease with no FDA-approved therapy targeting its genetic cause.

By Editor , 17 September 2026
Acarix Study Shows Acoustic Sensor Rivals Blood Test for Heart Failure

Oklahoma City – September 16, 2026 -- Acarix AB announced that a peer-reviewed study published in PLOS Digital Health found its seismocardiography (SCG) technology can detect heart failure with diagnostic accuracy comparable to NT-proBNP, the current standard blood test, while producing significantly fewer false positives.

By Editor , 17 September 2026
Vision Marine Invited to Suntex Marinas Conference After 60 Electric Boat Demos

Boisbriand, QC – September 16, 2026 -- Vision Marine Technologies Inc. (NASDAQ: VMAR) has been invited to the Suntex Marinas National Conference in Texas, running September 22-25, 2026, following its role as Title Sponsor of the Lake Berryessa Electric Boat Festival in June 2026 at Suntex-owned Pleasure Cove Marina in Napa, California.

By Editor , 17 September 2026
ECOSSE Opens Public Phase for $ECOS Token, Advances Whisky RWA Plan

St Cyrus, Scotland – September 16, 2026 -- ECOSSE has moved into its public phase following a September 4 launch, shifting the project from pre-launch activity to live platform operations built around its $ECOS token and a separate whisky-focused real-world-asset (RWA) initiative.

Public phase follows September 4 launch and prior token sale activity

The $ECOS Token Sale was already live ahead of the official launch date. With the public phase now active, participants can track vesting schedules and claim allocations as scheduled portions become available.